Rebate contracts: reasons not to substitute

21. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie (GAA) - 21st Annual Meeting of the German Drug Utilisation Research Group (GAA), 20.11. - 21.11.2014, Bonn.

vandusen.dimdi.de/static/de/meetings/gaa2014/14gaa28.shtml

Conflicts of interests: none declared.

Zielpreise für Leitsubstanzen: Verantwortungsteilung zwischen Arzt und Apotheker

Marktanteilsanalyse zum TK-Rabattvertrag

Incidence of thyroid hormone therapy in patients treated with sunitinib or sorafenib: A cohort study.

Switching the pharmaceutical dosage form of extended-release valproate is associated with therapeutic modification of antiepileptic therapy

Effect of switching branded risedronate to branded or generic alendronate on medication compliance with weekly bisphosphonates: a cohort study utilizing the dapi prescription claims database

Medication persistence with ginkgo biloba drugs of different dosage strengths - Persistenz bei Ginkgo biloba-Arzneimitteln unterschiedlicher Wirkstärke.

Dosage strength is associated with medication persistence with Ginkgo biloba drug products: a cohort study of ambulatory drug claims data in Germany